Contents

CNS & Neurological Disorders - Drug Targets , Volume 12 - Number 2

Editorial (Current and Emerging Pharmacological Therapies of Ischaemic Stroke)

, 12(2): 143 - 144

Ruoli Chen


DOI: 10.2174/1871527311312020001




Thrombolytic Agents for Acute Ischaemic Stroke Treatment: The Past, Present and Future

, 12(2): 145 - 154

Joyce S. Balami, Ruoli Chen, Brad A. Sutherland and Alastair M. Buchan


DOI: 10.2174/18715273113129990057




Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

, 12(2): 155 - 169

Joyce S. Balami, Brad A. Sutherland and Alastair M. Buchan


DOI: 10.2174/18715273112119990050




Mechanical Thrombectomy in Acute Ischaemic Stroke: A Review of the Literature, Clinical Effectiveness and Future Use

, 12(2): 170 - 190

Frank Lally, Iris Q. Grunwald, Ranjan Sanyal, Indira Natarajan and Christine Roffe


DOI: 10.2174/18715273112119990054




Lipoxygenase: An Emerging Target for Stroke Therapy

, 12(2): 191 - 199

Klaus van Leyen


DOI: 10.2174/18715273112119990053




Therapeutics Targeting Nogo-A Hold Promise for Stroke Restoration

, 12(2): 200 - 208

Prateek Kumar and Lawrence D.F. Moon


DOI: 10.2174/1871527311312020006




Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment

, 12(2): 209 - 219

Joyce S. Balami, Rosemary A. Fricker and Ruoli Chen


DOI: 10.2174/1871527311312020007




Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice

, 12(2): 220 - 227

Min Wang, Yongming Wang, Jing He, Siyu Wei, Na Zhang, Fengyong Liu, Xin Liu, Yi Kang and Xiaomei Yao


DOI: 10.2174/18715273113129990058




Different Factors Influence Recanalisation Rate After Coiling in Ruptured and Unruptured Intracranial Aneurysms

, 12(2): 228 - 232

Iris Q. Grunwald, Joyce S. Balami, Daniela Weber, Jessica Mutter, Anna L. Kuhn, Christoph Krick, Wolfgang Reith, Panagiotis Papanagiotou and Kaveh Shariat


DOI: 10.2174/18715273112119990055




Current Management and Treatment of Cerebral Vasospasm Complicating SAH

, 12(2): 233 - 241

Anna Luisa Kuhn, Joyce Saleh Balami and Iris Quasar Grunwald


DOI: 10.2174/1871527311312020010




New Thrombin and Factor Xa Inhibitors for Primary and Secondary Prevention of Ischaemic Stroke

, 12(2): 242 - 251

Lisa Winstanley and Ruoling Chen


DOI: 10.2174/18715273112119990051




The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review

, 12(2): 252 - 264

Domenico De Berardis, Stefano Marini, Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Monica Mazza, Alessandro Valchera, Michele Fornaro, Marilde Cavuto, Venkataramanujam Srinivasan, Gianna Sepede, Giovanni Martinotti and Massimo Di Giannantonio


DOI: 10.2174/1871527311312020012




Clinical Improvement and Cortical Adaptations After Functional Electrical Stimulation in Parkinson’s Disease Patients

, 12(2): 265 - 273

L. Popa, A. Constantinescu, D.F. Muresanu, A. Irimie, N.R. Balanescu and C.D. Popescu


DOI: 10.2174/1871527311312020013




TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies

, 12(2): 274 - 293

Maria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, Matteo Santoni and Massimo Nabissi


DOI: 10.2174/18715273113129990056




Commentary((Research Highlights)(Amyotrophic Lateral Sclerosis: Targeting the Body’s Energy Engine))

, 12(2): 294

Stephen D. Skaper


DOI: 10.2174/1871527311312020015




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science